These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


349 related items for PubMed ID: 8943063

  • 21. Inhibition of HIV type 1 BaL replication by MIP-1alpha, MIP-1beta, and RANTES in macrophages.
    Capobianchi MR, Abbate I, Antonelli G, Turriziani O, Dolei A, Dianzani F.
    AIDS Res Hum Retroviruses; 1998 Feb 10; 14(3):233-40. PubMed ID: 9491913
    [Abstract] [Full Text] [Related]

  • 22. C-C chemokine RANTES and HIV long terminal repeat-driven gene expression.
    Garzino-Demo A, Arya SK, Devico AL, Cocchi F, Lusso P, Gallo RC.
    AIDS Res Hum Retroviruses; 1997 Nov 01; 13(16):1367-71. PubMed ID: 9359655
    [Abstract] [Full Text] [Related]

  • 23. Role of beta-chemokines in suppressing HIV replication.
    Mackewicz CE, Barker E, Levy JA.
    Science; 1996 Nov 22; 274(5291):1393-5. PubMed ID: 8966605
    [No Abstract] [Full Text] [Related]

  • 24. Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines.
    Barker E, Bossart KN, Levy JA.
    Proc Natl Acad Sci U S A; 1998 Feb 17; 95(4):1725-9. PubMed ID: 9465084
    [Abstract] [Full Text] [Related]

  • 25. CD8+ cells in HIV infection produce macrophage inflammatory protein-1 alpha and RANTES: a comparative study in long-term survivors and progressor patients.
    Zanussi S, D'Andrea M, Simonelli C, Battiston V, Tirelli U, De Paoli P.
    Immunol Lett; 1996 Nov 17; 53(2-3):105-8. PubMed ID: 9024986
    [Abstract] [Full Text] [Related]

  • 26. Nitric oxide regulates MIP-1alpha expression in primary macrophages and T lymphocytes: implications for anti-HIV-1 response.
    Sherry B, Schmidtmayerova H, Zybarth G, Dubrovsky L, Raabe T, Bukrinsky M.
    Mol Med; 2000 Jun 17; 6(6):542-9. PubMed ID: 10972089
    [Abstract] [Full Text] [Related]

  • 27. CD8+ T-cell-mediated suppression of HIV-1 infection may not be due to chemokines RANTES, MIP-1 alpha and MIP-1 beta.
    Chen Y, Gupta P.
    AIDS; 1996 Oct 17; 10(12):1434-5. PubMed ID: 8902077
    [No Abstract] [Full Text] [Related]

  • 28. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.
    Trkola A, Paxton WA, Monard SP, Hoxie JA, Siani MA, Thompson DA, Wu L, Mackay CR, Horuk R, Moore JP.
    J Virol; 1998 Jan 17; 72(1):396-404. PubMed ID: 9420238
    [Abstract] [Full Text] [Related]

  • 29. Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir.
    Bisset LR, Rothen M, Joller-Jemelka HI, Dubs RW, Grob PJ, Opravil M.
    AIDS; 1997 Mar 15; 11(4):485-91. PubMed ID: 9084796
    [Abstract] [Full Text] [Related]

  • 30. A novel role for tumor necrosis factor-alpha in regulating susceptibility of activated CD4+ T cells from human and nonhuman primates for distinct coreceptor using lentiviruses.
    Brice GT, Mayne AE, Villinger F, Ansari AA.
    J Acquir Immune Defic Syndr; 2000 May 01; 24(1):10-22. PubMed ID: 10877490
    [Abstract] [Full Text] [Related]

  • 31. RANTES, MIP-1 alpha and MIP-1 beta are not involved in the inhibition of HIV-1SF33 replication mediated by CD8+ T-cell clones.
    Paliard X, Lee AY, Walker CM.
    AIDS; 1996 Oct 01; 10(12):1317-21. PubMed ID: 8902059
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
    Xiang J, George SL, Wünschmann S, Chang Q, Klinzman D, Stapleton JT.
    Lancet; 2004 Jun 19; 363(9426):2040-6. PubMed ID: 15207954
    [Abstract] [Full Text] [Related]

  • 33. Transendothelial chemotaxis of human alpha/beta and gamma/delta T lymphocytes to chemokines.
    Roth SJ, Diacovo TG, Brenner MB, Rosat JP, Buccola J, Morita CT, Springer TA.
    Eur J Immunol; 1998 Jan 19; 28(1):104-13. PubMed ID: 9485190
    [Abstract] [Full Text] [Related]

  • 34. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW, Justement JS, Moir S, Hallahan CW, Ehler LA, Liu S, McLaughlin M, Dybul M, Mican JM, Fauci AS.
    Proc Natl Acad Sci U S A; 2001 Jan 02; 98(1):253-8. PubMed ID: 11136258
    [Abstract] [Full Text] [Related]

  • 35. Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta.
    Annunziato F, Galli G, Nappi F, Cosmi L, Manetti R, Maggi E, Ensoli B, Romagnani S.
    Blood; 2000 Feb 15; 95(4):1167-74. PubMed ID: 10666186
    [Abstract] [Full Text] [Related]

  • 36. Do beta-chemokines have clinical relevance in HIV infection?
    Mackewicz CE, Barker E, Greco G, Reyes-Teran G, Levy JA.
    J Clin Invest; 1997 Aug 15; 100(4):921-30. PubMed ID: 9259592
    [Abstract] [Full Text] [Related]

  • 37. Induction of human immunodeficiency virus type 1 replication in human glial cells after proinflammatory cytokines stimulation: effect of IFNgamma, IL1beta, and TNFalpha on differentiation and chemokine production in glial cells.
    Janabi N, Di Stefano M, Wallon C, Hery C, Chiodi F, Tardieu M.
    Glia; 1998 Aug 15; 23(4):304-15. PubMed ID: 9671961
    [Abstract] [Full Text] [Related]

  • 38. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.
    Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P.
    Science; 1995 Dec 15; 270(5243):1811-5. PubMed ID: 8525373
    [Abstract] [Full Text] [Related]

  • 39. Difference in susceptibility to CC-chemokines among HIV-1 isolates.
    Gao M, Tsuchie H, Jin TQ, Zhang J, Detorio MA, Hossain MM, Taniguchi K, Kurimura T.
    Int J STD AIDS; 1998 Aug 15; 9(8):471-5. PubMed ID: 9702596
    [Abstract] [Full Text] [Related]

  • 40. C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection.
    Scala E, D'Offizi G, Rosso R, Turriziani O, Ferrara R, Mazzone AM, Antonelli G, Aiuti F, Paganelli R.
    J Immunol; 1997 May 01; 158(9):4485-92. PubMed ID: 9127015
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.